Crescent Biopharma Inc (CBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Crescent Biopharma Inc-Aktie (CBIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	1.039	-	-	-
Operating Expenses	9.18% 28.13	25.77	102.34	25.89	21.03
Operating Income/Loss	6.61% -26.36	-24.73	-91.49	-25.89	-21.03
Income Tax Expense/Benefit	-	-	2.00	-	-
Net Income/Loss	6.67% -24.84	-23.28	-92.40	-24.61	-21.79
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	6.28% -2.148	-2.021	-11.34	-3.66	-2.786

PHAT

$7.50

1.35%

ZVRA

$10.27

0.39%

SLDB

$5.74

5.03%

NVCT

$18.93

5.17%

CLYM

$10.91

6.03%

WVE

$3.19

3.24%